Oncology Institute Inc Cash Flow-to-Debt Ratio
Oncology Institute Inc cash flow-to-debt ratio. Oncology Institute Inc (TOI) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of $-2.21 Million could theoretically repay 0% of its total liabilities ($184.51 Million) in one year. Check Oncology Institute Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncology Institute Inc (2019–2025)
Cash flow-to-debt ratio of Oncology Institute Inc from 2019 to 2025. Historical debt coverage capacity for Oncology Institute Inc across 7 annual periods. Check TOI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Oncology Institute Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Oncology Institute Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Oncology Institute Inc. For the full cash flow conversion analysis, see Oncology Institute Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-24.59 Million | $180.38 Million | ▲ +13.1% |
| 2024 | -0.16x | $-26.54 Million | $169.13 Million | ▲ +34.2% |
| 2023 | -0.24x | $-36.31 Million | $152.22 Million | ▲ +46.5% |
| 2022 | -0.45x | $-61.76 Million | $138.49 Million | ▼ -35.5% |
| 2021 | -0.33x | $-32.68 Million | $99.28 Million | ▼ -2535.6% |
| 2020 | 0.01x | $508.00K | $37.59 Million | ▼ -93.5% |
| 2019 | 0.21x | $3.62 Million | $17.30 Million | — |